V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20206386 | 20077181 | 1.54 | 74 | Curative (C) | 2019-10-16 | 2019-11-03 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 101119173 |
| 20206389 | 20077182 | 1.67 | 106.4 | Palliative (P) | 2019-06-22 | 2019-07-12 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101432036 |
| 20206391 | 20077183 | 1.77 | 47.6 | Neo-adjuvant (N) | 2017-02-26 | 2017-03-06 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100494371 |
| 20206392 | 20077184 | 0 | 0 | Palliative (P) | null | 2019-10-04 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101371079 |
| 20206394 | 20077185 | 0 | 0 | 03 | 2018-09-04 | 2018-09-10 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100617456 |
| 20206395 | 20077186 | 1.53 | 53.2 | null | 2017-03-16 | 2017-03-16 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101495600 |
| 20206397 | 20077187 | 1.52 | 55 | Palliative (P) | 2017-06-25 | 2017-07-05 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100988148 |
| 20206399 | 20077188 | 1.67 | 88.7 | 03 | 2017-05-18 | 2017-06-05 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101858476 |
| 20206401 | 20077189 | 1.62 | 80.5 | Neo-adjuvant (N) | null | 2018-11-25 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101058380 |
| 20206406 | 20077190 | 1.67 | 61.8 | Palliative (P) | 2018-04-10 | 2018-04-22 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101007867 |
| 20206411 | 20077191 | 1.66 | 74.4 | null | 2018-07-16 | 2018-07-16 | Capecitabine (21days) + Carboplatin | N | null | CAPECITABINE + CARBOPLATIN | 101636289 |
| 20206414 | 20077192 | 1.85 | 112 | 03 | 2019-03-05 | 2019-03-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100656874 |
| 20206417 | 20077193 | 1.6 | 93.8 | null | 2019-01-02 | 2019-01-10 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100928508 |
| 20206418 | 20077194 | 1.76 | 74.6 | Palliative (P) | 2017-11-17 | 2017-11-17 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101774532 |
| 20206423 | 20077195 | 1.6 | 44 | null | 2018-01-20 | 2018-01-20 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101311372 |
| 20206427 | 20077196 | 1.58 | 78.5 | null | 2016-04-17 | 2016-04-25 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100487823 |
| 20206428 | 20077197 | 0 | 0 | Palliative (P) | 2020-04-27 | 2020-05-30 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100036712 |
| 20206430 | 20077198 | 1.72 | 113 | Adjuvant (A) | 2019-09-21 | 2019-10-18 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 101000596 |
| 20206435 | 20077199 | 1.79 | 58.8 | Neo-adjuvant (N) | 2004-12-25 | 2018-11-06 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101802963 |
| 20206436 | 20077200 | 1.57 | 76 | Neo-adjuvant (N) | 2017-05-10 | 2017-05-10 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101065245 |
| 20206439 | 20077201 | 1.54 | 74.15 | 01 | 2017-09-20 | 2017-10-07 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101366235 |
| 20206441 | 20077202 | 1.51 | 61.4 | Neo-adjuvant (N) | 2018-11-14 | 2018-11-17 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100545680 |
| 20206443 | 20077203 | 1.72 | 43.9 | Neo-adjuvant (N) | 2018-02-01 | 2018-02-01 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101450822 |
| 20206445 | 20077204 | null | null | Neo-adjuvant (N) | 2019-01-03 | 2019-01-19 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 100569326 |
| 20206446 | 20077205 | 0 | 0 | Curative (C) | 2017-09-22 | 2017-09-22 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100115984 |
| 20206453 | 20077206 | 0 | 0 | Curative (C) | null | 2016-07-24 | Capecitabine (21days) + Carboplatin | 02 | Y | DOXORUBICIN EMBOLISATION | 101592799 |
| 20206458 | 20077207 | 1.73 | 55.9 | null | 2017-02-13 | 2017-02-22 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101697266 |
| 20206461 | 20077208 | 1.72 | 88 | Neo-adjuvant (N) | 2017-08-31 | 2017-09-07 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101265540 |
| 20206464 | 20077209 | 1.49 | 81.9 | Neo-adjuvant (N) | 2017-12-31 | 2018-01-21 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100114638 |
| 20206467 | 20077210 | 1.76 | 51.4 | Neo-adjuvant (N) | 2017-11-12 | 2017-11-26 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101362103 |
| 20206476 | 20077211 | 1.53 | 67.9 | Curative (C) | 2017-05-27 | 2017-06-29 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100320282 |
| 20206478 | 20077212 | 1.71 | 110.1 | Adjuvant (A) | 2016-07-22 | 2016-08-02 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101676788 |
| 20206480 | 20077213 | null | 82.2 | null | 2016-10-25 | 2016-11-21 | Doxorubicin chemoembolisation | N | null | DOXORUBICIN EMBOLISATION | 100364677 |
| 20206485 | 20077214 | 1.62 | 60.2 | Curative (C) | 2015-05-09 | 2015-05-19 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 101239876 |
| 20206486 | 20077215 | 1.67 | null | Palliative (P) | 2019-02-02 | 2019-03-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101170594 |
| 20206489 | 20077216 | 1.72 | 77 | Curative (C) | 2020-09-03 | 2020-10-01 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100574255 |
| 20206491 | 20077217 | 0 | 0 | Palliative (P) | 2018-07-15 | 2018-08-06 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100309641 |
| 20206492 | 20077218 | 1.66 | 102 | Curative (C) | 2018-08-27 | 2018-09-25 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101605323 |
| 20206493 | 20077219 | null | 0 | Palliative (P) | 2016-09-17 | 2016-09-29 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101303715 |
| 20206496 | 20077220 | 1.74 | null | Curative (C) | 2017-03-05 | 2017-03-12 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 101406388 |
| 20206500 | 20077221 | 1.65 | 83.3 | Palliative (P) | 2019-11-30 | 2019-11-30 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 101347814 |
| 20206502 | 20077222 | 1.68 | 97 | null | 2019-03-20 | 2019-03-20 | CISPLATIN + FLUOROURACIL + RT | 2 | null | CISPLATIN + FLUOROURACIL | 101638305 |
| 20206504 | 20077223 | 1.68 | 56.5 | Palliative (P) | 2018-01-04 | 2018-02-03 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100382091 |
| 20206506 | 20077224 | 1.66 | 79.75 | Palliative (P) | 2017-10-02 | 2017-10-02 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 101461645 |
| 20206507 | 20077225 | 1.67 | 93.5 | Palliative (P) | 2017-10-27 | 2017-10-27 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101620051 |
| 20206508 | 20077226 | 1.79 | 104 | Neo-adjuvant (N) | 2018-01-23 | 2018-02-09 | Capecitabine (21days) + Carboplatin | 2 | null | DOXORUBICIN EMBOLISATION | 100237006 |
| 20206509 | 20077227 | 1.82 | 56 | Curative (C) | 2016-08-13 | 2016-08-14 | Cisplatin + Fluorouracil + RT 5day | 02 | Y | CISPLATIN + FLUOROURACIL | 100394305 |
| 20206510 | 20077228 | 1.67 | 43 | 03 | 2018-10-18 | 2018-10-22 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101115704 |
| 20206511 | 20077229 | 0 | 0 | null | 2017-02-10 | 2017-02-10 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100360357 |
| 20206512 | 20077230 | 1.81 | 82 | Palliative (P) | 2018-05-10 | 2018-05-29 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100318635 |